1. Global Hospital-acquired Disease Testing Market 2015-2019 is the latest addition to ReportsnReports.com industry research reports collection. The report is about 43 exhibits and 92 pages published in July-2015. The analysts forecast global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital- acquired infections are SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and gastrointestinal illnesses. These infections appear between 48 hours and four days after a patient is admitted and are usually related to a treatment of procedure used to treat or diagnose the patient's initial illness or injury. Hospital-acquired diseases are preventable through adherence to strict guidelines and less usage of invasive equipment that must be followed by healthcare professionals while caring for the patient. Covered in this Report In this report, The covers the present scenario and the growth prospects of the global hospital-acquired disease testing market for the period 2015-2019. To calculate the market size, we consider revenue generated from the sales of testing products used in the following hospital-acquired disease infections: SSIs, UTIs, bloodstream infections, pneumococcal infections, MRSA, and others. Inquire for this report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=40776 2 The report, Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Key Regions Americas, APAC and EMEA Key Players - Abbott Laboratories Inc., Becton and Dickenson (BD), bioMerieux SA and Roche Diagnostics Other Prominent Vendors in the market are: Akers Biosciences, Alere, Beckman Coulter/Danaher, Cantel Medical, Cepheid, Diatherix Laboratories, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Gen-Probe, Humor Diagnostica, Life Technologies, Meridian Bioscience, Nordion and QIAGEN Purchase a Copy of the Report @ http://www.reportsnreports.com/Purchase.aspx?name=407762 Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=407762 Market Driver - Rising Prevalence of HAIs
2. Market Challenge - Lack of Healthcare Infrastructure Market Trend - Technological Advancements Special Offer on Technavio/ Infiniti Reports (http://www.reportsnreports.com/publisher/infiniti-research-limited/ ): Buy 3 reports at the coast of 2 (Lowest Priced Report will be free) Buy 4 and more reports and get 50% flat discount on the total Price Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Contact firstname.lastname@example.org / Call +1 888 391 5441 for further information on Global Hospital-acquired Disease Testing Market 2015-2019 report OR for any other market research and intelligence needs you may have for your business.